Articles by Stephanie Sutton - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Stephanie Sutton
« Previous
123456789101112
Next »

Hameln Pharmaceuticals Receives FDA Warning Letter

Jan 16, 2013
By: Stephanie Sutton

FDA has issued a Warning Letter to Hameln Pharmaceuticals GmbH after observing "significant" cGMP violations for finished pharmaceuticals at the company?s facility in Hameln, Germany.

EMA Updates Guideline for Anticancer Medicines

Jan 14, 2013
By: Stephanie Sutton

The European Medicines Agency has revised its guideline for the evaluation of anticancer medicinal products.

Partnership Aims to Advance Malaria Vaccine R&D

Jan 7, 2013
By: Stephanie Sutton

The PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals have announced a follow-on collaboration to advance the development of malaria vaccines and new vaccine delivery technologies.

Pharma Conversation & Community

A round up of news from across the web, including trends from social social media platforms.
Jan 2, 2013
By: Stephanie Sutton

A round up of news from across the web, including trends from social social media platforms.

EMA Reveals Work Programme for 2013

Dec 31, 2012
By: Stephanie Sutton

The management board of the European Medicines Agency (EMA) has endorsed the agency?s work programme and budget for 2013, which includes a budget of EUR231.6 million, a slight increase over 2012.

GSK Partners with Vodafone for Vaccinations

Dec 24, 2012
By: Stephanie Sutton

GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.

Vivalis and Intercell to Create New Biotechnology Company

Dec 18, 2012
By: Stephanie Sutton

Vivalis and Intercell have agreed to the terms of a merger to create a new European biotechnology company called Valneva that will specialize in vaccines and antibodies.

EU Court Dismisses AstraZeneca Appeal

Dec 10, 2012
By: Stephanie Sutton

The Court of Justice of the European Union has dismissed an appeal by AstraZeneca concerning a 2005 decision that found the company guilty of abusing its dominant position in the marketplace.

EMA Publishes Plan to Deal with Supply Shortages

Dec 3, 2012
By: Stephanie Sutton

The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here